Cargando…
CCL22 to activate Treg migration and suppress depigmentation in vitiligo
In vitiligo, gradual cutaneous depigmentation and cytotoxic T cell activity against melanocytes is accompanied by a paucity of regulatory T cells (Tregs) in vitiligo patient skin, indicating that autoimmune responses are not adequately held in check. Thus we sought a means to repopulate patient skin...
Autores principales: | Eby, Jonathan M., Kang, Hee-Kap, Tully, Sean T., Bindeman, Wendy E., Peiffer, Daniel S., Chatterjee, Shilpak, Mehrotra, Shikhar, Le Poole, I. Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044299/ https://www.ncbi.nlm.nih.gov/pubmed/25634358 http://dx.doi.org/10.1038/jid.2015.26 |
Ejemplares similares
-
A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo
por: Chatterjee, Shilpak, et al.
Publicado: (2013) -
Antigen Specificity Enhances Disease Control by Tregs in Vitiligo
por: Mukhatayev, Zhussipbek, et al.
Publicado: (2020) -
PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin
por: Miao, Xiao, et al.
Publicado: (2018) -
Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011) -
CD38: T Cell Immuno-Metabolic Modulator
por: Kar, Anwesha, et al.
Publicado: (2020)